Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01752114 · ClinicalTrials.gov registry record
Early Diagnosis of Pulmonary Nodules
A clinical trial of Carcinoma and Precancerous Conditions, sponsored by Integrated Diagnostics.
- Completed
- Registry status
- 684
- Enrollment target
- 20
- Study locations
NCT01752114: Completed study of Carcinoma and Precancerous Conditions, sponsored by Integrated Diagnostics.
NCT01752114 is a study of Carcinoma and Precancerous Conditions that has completed, run by Integrated Diagnostics. The registered enrollment target is 684 participants, above the 231-participant average among 29 other Carcinoma trials with a reported enrollment target (196% higher). The trial reports 20 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01752114, a study of Carcinoma and Precancerous Conditions, has completed, sponsored by Integrated Diagnostics.
- COMPLETED
- Registry status
- 684 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study is intended to determine the positive predictive value (PPV) and negative predictive value (NPV) of the multiprotein classifier based on the observed study prevalence of Non-Small Cell Lung Cancer (NSCLC) in the study participants.
Primary Outcome
Incidence rate of Non-Small Cell Lung Cancer as determined by histologic or cytologic diagnosis and/or radiographically stability at 2 years post enrollment.
Conditions Studied
Study Locations (20)
North Carolina
- Charleston Research Institute - Charleston
- Carolinas HealthCare System - Charlotte
- LeBaurer Healthcare - Greensboro
Arizona
- St. Joseph's Hospital & Medical Center - Phoenix
- Pulmonary Associates of Southern Arizona - Tucson
California
- University of Southern California - Los Angeles
- California Pacific Medical Center - San Francisco
Maryland
- Pulmonary & Crit Care Associates of Baltimore - Baltimore
- Johns Hopkins Medical Center - Baltimore
Michigan
- Henry Ford Hospital - Detroit
- Beaumont Health System - Royal Oak
Minnesota
- Virginia Piper Cancer Institute - Allina Health - Minneapolis
- Mayo Clinic - Rochester
Florida
- Sarasota Memorial Hospital - Sarasota
Georgia
- Georgia Lung Associates - Austell
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 684 participants |
| Start Date | 2012-10 |
| Est. Completion | 2016-12-31 |
What the finished NCT01752114 record still lists
NCT01752114 is an observational study that tracks outcomes without assigning an intervention. The registered 684 participants enrollment target is mid-sized for trials with a published cap, above the 231-participant average among 29 other Carcinoma trials with a reported enrollment target (196% higher).
The record links to 2 conditions, with Carcinoma appearing as the primary indexed condition, and to 0 interventions.
NCT01752114 names 20 study sites across 13 states, led by North Carolina, Arizona, California.
Frequently Asked Questions
What is clinical trial NCT01752114 about?
NCT01752114 is a clinical study titled "Early Diagnosis of Pulmonary Nodules". This study is intended to determine the positive predictive value (PPV) and negative predictive value (NPV) of the multiprotein classifier based on the observed study prevalence of Non-Small Cell Lung Cancer (NSCLC) in the study participants.
What is the current status of trial NCT01752114?
This trial is currently completed. The enrollment target is 684 participants. The study started on 2012-10. Estimated completion is 2016-12-31.
What conditions does trial NCT01752114 study?
This clinical trial studies the following conditions: Carcinoma, Precancerous Conditions.
Who is sponsoring clinical trial NCT01752114?
This trial is sponsored by Integrated Diagnostics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01752114 being conducted?
This trial has 20 study locations across Arizona, California, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01752114's enrollment target sits among peer trials
684 3rd of 29 higher than 27 of 29 other Carcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Using a PET Imaging Agent, 18F-Clofarabine (CFA), to Measure Deoxycytidine Kinase Activity in Metastatic Cancer
RECRUITING · Early Phase 1
-
Study to Evaluate the Safety and Efficacy of Oral NRC-2694-A in Combination With Paclitaxel in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma, Who Progressed on or After Immune Checkpoint Inhibitor Therapy
RECRUITING · Phase 2
-
Preoperative Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck
RECRUITING · Phase 2
-
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
RECRUITING · Phase 1
-
Functional Near-Infrared Spectroscopy and Virtual Reality Relaxation Programs for Pain Management in Patients With Cancer
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06795087 · 684 participants
Discharge Medication Use Post-Operatively in GU Cancer Patients
- NCT05099770 · 685 participants · Phase 3
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
- NCT05880199 · 685 participants
BSGM to Evaluate Patients With GI Symptoms
- NCT04333537 · 686 participants · Phase 2
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia